CCR8 Antibody (1055C) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # FAB8324Z
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 1055C
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HEK293 human embryonic kidney cell line transfected with mouse CCR8
Accession # P56484
Accession # P56484
Specificity
Stains mouse CCR8 transfectants but not irrelevant transfectants in flow cytometry.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for CCR8 Antibody (1055C) [DyLight 755]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCR8
Alternate Names
CCR8, CD198, CDw198, ChemR1, CKRL1, GPRCL1, TER-1
Gene Symbol
CCR8
Additional CCR8 Products
Product Documents for CCR8 Antibody (1055C) [DyLight 755]
Product Specific Notices for CCR8 Antibody (1055C) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...